Renaissance Capital logo

Aesthetic Medical International Holdings Priced, Nasdaq: AIH

Operates aesthetic medical services centers in China.

Industry: Health Care

First Day Return: -16.4%

Industry: Health Care

We are a leading provider of aesthetic medical services in China. Leveraging over 20 years of clinical experience, we provide one-stop aesthetic service offerings that includes surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation and liposuction, non-surgical aesthetic treatments, which comprise minimally invasive treatments and energy-based treatments such as laser, ultrasound and ultraviolet light treatments, and other aesthetic services such as cosmetic dentistry, as well as general medical services. According to Frost & Sullivan, we are the third largest private aesthetic medical services provider in China in terms of revenue in 2018.
more less
IPO Data
IPO File Date 09/30/2019
Offer Price $12.00
Price Range $11.00 - $13.00
Offer Shares (mm) 2.5
Deal Size ($mm) $30
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/24/2019
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $30
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Shenzhen, China
Founded 1997
Employees at IPO 1,687
Website www.pengai.com.cn

Aesthetic Medical International Holdings (AIH) Performance